Alan R. Eastman

  • Professor of Molecular and Systems Biology

  • Director, Molecular Therapeutics Program, NCCC

Cancer chemotherapy. Mechanisms of drug action: unbiased screen for novel drug targets and identification of selective anticancer drugs. Novel drug combinations: modulation of cell cycle arrest induced by DNA damaging agents; modulation of Bcl-2 proteins to enhance apoptosis.


Rubin 662
HB 7936


Chester Beatty Research Institute, University of London, Ph.D. 1975